Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review

Abstract Background and Aims The present study aimed to review probiotics' clinical efficacy in preventing infectious diseases among hospitalized patients in ICU and non‐ICU wards. Methods A search of Medline, EMBASE, The Cochrane Library, Science Direct, Open Grey, and Google Scholar was condu...

Full description

Bibliographic Details
Main Authors: Atieh Darbandi, Maryam Banar, Maryam Koupaei, Roghayeh Afifirad, Parisa Asadollahi, Elnaz Bafandeh, Iraj Rasooli, Amir Emamie, Tahereh Navidifar, Parviz Owlia
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.1469
_version_ 1827698817600847872
author Atieh Darbandi
Maryam Banar
Maryam Koupaei
Roghayeh Afifirad
Parisa Asadollahi
Elnaz Bafandeh
Iraj Rasooli
Amir Emamie
Tahereh Navidifar
Parviz Owlia
author_facet Atieh Darbandi
Maryam Banar
Maryam Koupaei
Roghayeh Afifirad
Parisa Asadollahi
Elnaz Bafandeh
Iraj Rasooli
Amir Emamie
Tahereh Navidifar
Parviz Owlia
author_sort Atieh Darbandi
collection DOAJ
description Abstract Background and Aims The present study aimed to review probiotics' clinical efficacy in preventing infectious diseases among hospitalized patients in ICU and non‐ICU wards. Methods A search of Medline, EMBASE, The Cochrane Library, Science Direct, Open Grey, and Google Scholar was conducted for eligible publications from 2002 to 2020 following the requirements outlined in the PRISMA guideline. The search strategy was based on the combination of the following terms: “probiotics,” “prebiotics,” “synbiotics,” and “cross‐infection.” The logical operators “AND” (or the equivalent operator for the databases) and “OR” (e.g., probiotics OR prebiotics OR synbiotics) were used. Results The results indicated that the probiotic consumption caused a significant reduction in antibiotic‐associated diarrhea (AAD) and Clostridioides difficile infection (CDI) in 2/8 randomized clinical trials (RCTs) investigating AAD/CDI. Also, 5/12 clinical trials highlighted the considerable effects of probiotics on the reduction or prevention of ventilator associated pneumoniae (VAP), so the mean prevalence of VAP was lower in the probiotic group than in the placebo group. The total rate of nosocomial infections among preterm infants was nonsignificantly higher in the probiotic group compared to the control group. Conclusion This systematic review shows that the administration of probiotics has moderate preventive or mitigating effects on the occurrence of VAP in ICU patients, CDI, AAD, and nosocomial infections among children. Consequently, applying antibiotics along with the proper probiotic species can be advantageous.
first_indexed 2024-03-10T13:37:24Z
format Article
id doaj.art-0a0448ef088d4bad8687c1a7a38d43cf
institution Directory Open Access Journal
issn 2398-8835
language English
last_indexed 2024-03-10T13:37:24Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj.art-0a0448ef088d4bad8687c1a7a38d43cf2023-11-21T06:37:12ZengWileyHealth Science Reports2398-88352023-08-0168n/an/a10.1002/hsr2.1469Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic reviewAtieh Darbandi0Maryam Banar1Maryam Koupaei2Roghayeh Afifirad3Parisa Asadollahi4Elnaz Bafandeh5Iraj Rasooli6Amir Emamie7Tahereh Navidifar8Parviz Owlia9Molecular Microbiology Research Center Shahed University Tehran IranDepartment of Pathobiology School of Public Health, Tehran University of Medical Sciences Tehran IranDepartment of Microbiology and Immunology School of Medicine, Kashan University of Medical Sciences Kashan IranDepartment of Microbiology School of Medicine, Tehran University of Medical Sciences Tehran IranDepartment of Microbiology Faculty of Medicine, Ilam University of Medical Sciences Ilam IranDepartment of Medical Biotechnology Faculty of Medicine, Lorestan University of Medical Sciences Khorramabad IranMolecular Microbiology Research Center, Faculty of Sciences Shahed University Tehran IranDepartment of Pathobiology School of Public Health, Tehran University of Medical Sciences Tehran IranDepartment of Basic Sciences Shoushtar Faculty of Medical Sciences Shoushtar IranMolecular Microbiology Research Center Shahed University Tehran IranAbstract Background and Aims The present study aimed to review probiotics' clinical efficacy in preventing infectious diseases among hospitalized patients in ICU and non‐ICU wards. Methods A search of Medline, EMBASE, The Cochrane Library, Science Direct, Open Grey, and Google Scholar was conducted for eligible publications from 2002 to 2020 following the requirements outlined in the PRISMA guideline. The search strategy was based on the combination of the following terms: “probiotics,” “prebiotics,” “synbiotics,” and “cross‐infection.” The logical operators “AND” (or the equivalent operator for the databases) and “OR” (e.g., probiotics OR prebiotics OR synbiotics) were used. Results The results indicated that the probiotic consumption caused a significant reduction in antibiotic‐associated diarrhea (AAD) and Clostridioides difficile infection (CDI) in 2/8 randomized clinical trials (RCTs) investigating AAD/CDI. Also, 5/12 clinical trials highlighted the considerable effects of probiotics on the reduction or prevention of ventilator associated pneumoniae (VAP), so the mean prevalence of VAP was lower in the probiotic group than in the placebo group. The total rate of nosocomial infections among preterm infants was nonsignificantly higher in the probiotic group compared to the control group. Conclusion This systematic review shows that the administration of probiotics has moderate preventive or mitigating effects on the occurrence of VAP in ICU patients, CDI, AAD, and nosocomial infections among children. Consequently, applying antibiotics along with the proper probiotic species can be advantageous.https://doi.org/10.1002/hsr2.1469antibiotic‐associated diarrheaClostridioides difficile infectionnosocomial infectionsprobioticventilator‐associated pneumonia
spellingShingle Atieh Darbandi
Maryam Banar
Maryam Koupaei
Roghayeh Afifirad
Parisa Asadollahi
Elnaz Bafandeh
Iraj Rasooli
Amir Emamie
Tahereh Navidifar
Parviz Owlia
Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
Health Science Reports
antibiotic‐associated diarrhea
Clostridioides difficile infection
nosocomial infections
probiotic
ventilator‐associated pneumonia
title Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
title_full Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
title_fullStr Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
title_full_unstemmed Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
title_short Clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in ICU and non‐ICU wards in clinical randomized trials: A systematic review
title_sort clinical efficacy of probiotics in prevention of infectious diseases among hospitalized patients in icu and non icu wards in clinical randomized trials a systematic review
topic antibiotic‐associated diarrhea
Clostridioides difficile infection
nosocomial infections
probiotic
ventilator‐associated pneumonia
url https://doi.org/10.1002/hsr2.1469
work_keys_str_mv AT atiehdarbandi clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT maryambanar clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT maryamkoupaei clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT roghayehafifirad clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT parisaasadollahi clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT elnazbafandeh clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT irajrasooli clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT amiremamie clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT taherehnavidifar clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview
AT parvizowlia clinicalefficacyofprobioticsinpreventionofinfectiousdiseasesamonghospitalizedpatientsinicuandnonicuwardsinclinicalrandomizedtrialsasystematicreview